Compare LUNG & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUNG | ULBI |
|---|---|---|
| Founded | 1995 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 104.3M |
| IPO Year | 2020 | 1995 |
| Metric | LUNG | ULBI |
|---|---|---|
| Price | $2.53 | $15.65 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.70 | N/A |
| AVG Volume (30 Days) | ★ 279.2K | 23.0K |
| Earning Date | 10-27-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.64 | N/A |
| EPS | N/A | ★ 13.00 |
| Revenue | $90,497,000.00 | ★ $191,159,000.00 |
| Revenue This Year | $0.06 | $17.65 |
| Revenue Next Year | $8.58 | N/A |
| P/E Ratio | ★ N/A | $0.48 |
| Revenue Growth | 8.01 | ★ 16.24 |
| 52 Week Low | $1.13 | $4.90 |
| 52 Week High | $2.66 | $8.25 |
| Indicator | LUNG | ULBI |
|---|---|---|
| Relative Strength Index (RSI) | 77.09 | 93.46 |
| Support Level | $1.20 | $5.79 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.13 | 0.25 |
| MACD | 0.07 | 0.60 |
| Stochastic Oscillator | 85.71 | 99.74 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.